Hepatitis due to herpes group viruses;Hepatitis por virus del grupo herpes

Enfermedades Infecciosas y Microbiologia Clinica

Volumn 24, Issue 6, 2006, Pages 392-398

  Cisneros Herreros, José M ^a   Herrero Romero, Marta ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

Author keywords

Cytomegalovirus; Epstein Barr virus; Hepatitis; Herpes simplex virus; Varicella zoster virus

Indexed keywords

ACICLOVIR; GANCICLOVIR;

BONE MARROW; CYTOMEGALOVIRUS; DEMOGRAPHY; DIFFERENTIAL DIAGNOSIS; EPSTEIN BARR VIRUS; HEPATITIS; HEPATITIS VIRUS; HERPES SIMPLEX; HERPES SIMPLEX VIRUS; HERPES VIRUS; HUMAN; HUMAN HERPESVIRUS 6; IMMUNOCOMPETENCE; LIVER GRAFT; PREGNANT WOMAN; PRIMARY INFECTION; PROTEIN EXPRESSION; REVIEW; SKIN DEFECT; SYMPTOMATOLOGY; VARICELLA ZOSTER VIRUS;

EID: 33746528081     PISSN: 0213005X     EISSN: None     Source Type: Journal    
DOI: 10.1157/13089695     Document Type: Article

References (35)

1. a ed. Vol. 2. Philadelphia: Churchill Livingstone; 2005. p. 1756-62.
2. a ed. Vol. 2. Philadelphia: Churchill Livingstone; 2005. p. 1762-80.
3. Minuk GY, Nicolle LE. Genital herpes and hepatitis in healthy young adults. J Med Virol. 1986;19:269-75.
4. Farr RW, Short S, Weissman D. Fulminant hepatitis during herpes simplex virus infection in apparently immunocompetent adults: report of two cases and review of the literature. Clin Infect Dis. 1997;24:1191-4.
5. Douglas HJ, Eger EI, Biava CG, Renzi C. Hepatic necrosis associated with viral infection after enflurane anesthesia. N Engl J Med. 1977;296:553-5.
6. Kang AH, Graves CR. Herpes simplex hepatitis in pregnancy: a case report and review of the literature. Obstet Gynecol Surv. 1999;54:463-8.
7. Verma A, Dhawan A, Zuckerman M, Hadzic N, Baker AJ, Mieli-Vergani G. Neonatal herpes simplex virus infection presenting as acute liver failure: prevalent role of herpes simplex virus type I. J Pediatr Gastroenterol Nutr. 2006;42:282-6.
8. Johnson JR, Egaas S, Gleaves CA, Hackman R, Bowden RA. Hepatitis due to herpes simplex virus in marrow-transplant recipients. Clin Infect Dis. 1992;14:38-45.
9. Kaufman B, Gandhi SA, Louie E, Rizzi R, Illei P. Herpes simplex virus hepatitis: case report and review. Clin Infect Dis. 1997;24:334-8.
10. a Recomendaciones de la SEIMC, 2005. Disponible en: http://www.seimc.org/protocolos/microbiologia/
11. Sharma S, Mosunjac M. Herpes simplex hepatitis in adults: a search for muco-cutaneous clues. J Clin Gastroenterol. 2004;38:697-704.
12. Brown ZA, Wald A, Morrow RA, Selke S, Zeh J, Corey L. Effect of serologic status and cesarean delivery on transmission rates of herpes simplex virus from mother to infant. JAMA. 2003;289:203-9.
13. Feldman S, Crout JD, Andrew ME. Incidence and natural history of chemically defined varicella-zoster virus hepatitis in children and adolescents. Scand J Infect Dis. 1997;29:33-6.
14. Kusne S, Pappo O, Manez R, Pazin G, Carpenter B, Fung JJ, et al. Varicella-zoster virus hepatitis and a suggested management plan for prevention of VZV infection in adult liver transplant recipients. Transplantation. 1995;60:619-21.
15. Os I, Strom EH, Stenehjem A, Gudmundsdottir H, Langberg H, Draganov B, et al. Varicella infection in a renal transplant recipient associated with abdominal pain, hepatitis, and glomerulonephritis. Scand J Urol Nephrol. 2001;35:330-3.
16. Soriano V, Bru F, González-Lahoz J. Fatal varicella hepatitis in a patient with AIDS. J Infect. 1992;25:107.
17. Ghaffar F, Carrick K, Rogers BB, Margraf LR, Krisher K, Ramilo O. Disseminated infection with varicella-zoster virus vaccine strain presenting as hepatitis in a child with adenosine deaminase deficiency. Pediatr Infect Dis J. 2000;19:764-6.
18. Mantadakis E, Anagnostatou N, Danilatou V, Markaki EA, Spanaki AM, Briassoulis G, et al. Fulminant hepatitis due to varicella zoster virus in a girl with acute lymphoblastic leukemia in remission: report of a case and review. J Pediatr Hematol Oncol. 2005;27:551-3.
19. Muñoz L, Balmana J, Martino R, Sureda A, Rabella N, Brunet S. Dolo abdominal como forma de presentación de infección visceral por el virus varicela zóster en receptores de trasplante de progenitores hematopoyéticos. Med Clin (Barc). 1998;111:19-22.
20. Caksen H, Guler E, Alper M, Ustunbas HB. A fatal case of Reye syndrome after varicella and ingestion of aspirin. J Dermatol. 2001;28:286-7.
21. Centers for Disease Control and Prevention. Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients: recommendations of CDC, the Infectious Disease Society of America, and the American Society of Blood and Marrow Transplantation. Biol Blood Marrow Transplantation. 2000;6:705-6.
22. Pérez JL, Cisneros JM. Infecciones por citomegalovirus. Tratado SEIMC de enfermedades infecciosas y microbiología clínica. Editorial Panamericana; 2006. p. 747-57.
23. Serna-Higuera C, González-García M, Milicua JM, Muñoz V. Acute cholestatic hepatitis by cytomegalovirus in an immunocompetent patient resolved with ganciclovir. J Clin Gastroenterol. 1999;29:276-7.
24. Shibata Y, Kitajima N, Kawada J, Sugaya N, Nishikawa K, Morishima T, et al. Association of cytomegalovirus with infantile hepatitis. Microbiol Immunol. 2005;49:771-7.
25. Patel R, Paya CV. Infections in solid-organ transplant recipients. Clin Microbiol Rev. 1997;10:86-124.
26. Seehofer D, Rayes N, Tullius SG, Schmidt CA, Neumann UP, Radke C, et al. CMV hepatitis after liver transplantation: incidence, clinical course, and long-term follow-up. Liver Transpl. 2002;8:1138-46.
27. Gane E, Saliba F, Valdecasas GJ, O'Grady J, Pescovitz MD, Lyman S, et al. Randomised trial of efficacy and safety of oral ganciclovir in the prevention of cytomegalovirus disease in liver-transplant recipients. The Oral Ganciclovir International Transplantation Study Group. Lancet. 1997;350:1729-33.
28. Torre-Cisneros J, Fortún J, Aguado JM, De la Cámara R, Cisneros JM, Gavaldá J, et al. Recomendaciones GESITRA-SEIMC y RESITRA sobre prevención y tratamiento de la infección por citomegalovirus en pacientes trasplantados. Enferm Infecc Microbiol Clin. 2005;23:424-37.
29. Paya C, Humar A, Domínguez E, Washburn K, Blumberg E, Alexander B, et al. Efficacy and safety of valganciclovir vs. oral ganciclovir for prevention of cytomegalovirus disease in solid organ transplant recipients. Am J Transplant. 2004;4:611-20.
30. De Bolle L, Naesens L, De Clercq E. Update on human herpesvirus 6 biology, clinical features, and therapy. Clin Microbiol Rev. 2005;18:217-45.
31. Harma M, Hockerstedt K, Krogerus L, Lautenschlager I. Pretransplant human herpesvirus 6 infection of patients with acute liver failure is a risk factor for post-transplant human herpesvirus 6 infection of the liver. Transplantation. 2006;81:367-72.
32. a ed. Vol 2. Philadelphia: Churchill Livingstone; 2005. p. 1801-20.
33. Milone MC, Tsai DE, Hodinka RL, Silverman LB, Malbran A, Wasik MA, et al. Treatment of primary Epstein-Barr virus infection in patients with X-linked lymphoproliferative disease using B-cell-directed therapy. Blood. 2005;105:994-6.
34. Kimura H, Morishima T, Kanegane H, Ohga S, Hoshino Y, Maeda A, et al. Prognostic factors for chronic active Epstein-Barr virus infection. J Infect Dis. 2003;187:527-33.
35. Nuckols JD, Baron PW, Stenzel TT, Olatidoye BA, Tuttle-Newhall JE, Clavien PA, et al. The pathology of liver-localized post-transplant lymphoproliferative disease: a report of three cases and a review of the literature. Am J Surg Pathol. 2000;24:733-41.